DUCHENE TODD M 4
4 · Core Scientific, Inc./tx · Filed Jun 3, 2026
Research Summary
AI-generated summary of this filing
Core Scientific (CORZ) Chief Legal & Admin Officer Todd Duchene Sells Shares
What Happened
Todd M. Duchene, Core Scientific's Chief Legal and Administrative Officer, sold a total of 10,000 shares in open-market transactions on June 1, 2026, disposing of: 1,300 shares at a weighted avg price of $26.93 ($35,007); 3,200 shares at $28.27 ($90,453); and 5,500 shares at $28.76 ($158,159). Total proceeds were approximately $283,619. These were sales (not purchases), which are often routine rather than a bullish signal.
Key Details
- Transaction date: 2026-06-01; Form 4 filed: 2026-06-03 (timely filing).
- Share breakdown and reported prices:
- 1,300 shares — $26.93 weighted average (sales ranged $26.54–$27.52) [Footnote F2]
- 3,200 shares — $28.27 weighted average (sales ranged $27.57–$28.56) [Footnote F3]
- 5,500 shares — $28.76 weighted average (sales ranged $28.58–$28.97) [Footnote F4]
- Total shares sold: 10,000; total proceeds ≈ $283,619.
- Shares owned after the transactions: not disclosed in the provided excerpt of the filing.
- Notable: Transactions were made under a pre-arranged Rule 10b5-1 trading plan adopted Dec 5, 2025 (Footnote F1). The weighted-average prices reflect multiple trades; the filer offers to provide per-trade price details on request.
Context
- A 10b5-1 plan typically means trades were pre-scheduled and may be routine, reducing the implication that sales reflect immediate insider views on the company.
- Sales (code "S") are less informative than purchases for signaling insider confidence; treat as factual disclosure rather than a recommendation.
Insider Transaction Report
Form 4
DUCHENE TODD M
See remarks
Transactions
- Sale
Common Stock
[F1][F2]2026-06-01$26.93/sh−1,300$35,007→ 2,087,595 total - Sale
Common Stock
[F1][F3]2026-06-01$28.27/sh−3,200$90,453→ 2,084,395 total - Sale
Common Stock
[F1][F4]2026-06-01$28.76/sh−5,500$158,159→ 2,078,895 total
Footnotes (4)
- [F1]The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 5, 2025.
- [F2]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.54 to $27.52, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
- [F3]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.57 to $28.56, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
- [F4]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.58 to $28.97, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
Signature
/s/ Todd DuChene|2026-06-03